’ve known for years that highly placed insiders in the FDA and USDA leave for jobs in the drug industry, biotech industry, medical device industry, or agribusiness, or vice versa, the so-called golden revolving door. High-level executives and attorneys have bounced back and forth from, for instance, an executive position at Merck or Monsanto to a post at the FDA or USDA. For example, Dr. Arthur Hull Hayes Jr. served as FDA commissioner for 2 years from 1981 to 1983. During his brief tenure, he personally overruled the 3-3 gridlocked vote for approval of aspartame as a sweetener despite nearly 2 decades of contentious debate and animal studies demonstrating that the sweetener was associated with cancerous tumors, and then he resigned to work as a high-paid consultant for the public relations firm used by aspartame’s manufacturer, G.D. Searle, a subsidiary of Monsanto